Medical News
August 17th, 2009
The US FDA has approved Saphris sublingual tablets for the acute therapy of schizophrenic adults, as well as the acute therapy of manic or mixed bipolar I disorder, with or without adult psychotic attributes. Saphris is endorsed for first-line therapy, and is the first prescription drug to receive primary consent for both of these symptoms concurrently.
August 13th, 2009
A recent study challenges the medical community, suggesting that breast cancer patients with isolated tumor cells or small lymphatic “micrometastases,” benefit from adjuvant type therapy, such as post-surgical chemotherapy or hormonal therapy.
August 13th, 2009
A study set to appear in CA: A Cancer Journal for Clinicians, believes that the use of MRI’s to determine the degree of early breast cancer in women before surgery, may be more harmful than good.
August 13th, 2009
Specialty pharmaceutical company, who specializes in the generation of revolutionary products to treat neurological and psychiatric diseases, publicizes top-line results from the Phase III Zelrix clinical tria
August 13th, 2009
The U.S. FDA has recently announced two rules that are intended to explicate accessible strategies for critically ill patients who are interested in obtaining access to investigational drugs and biologics.
August 12th, 2009
Researchers from the University of California have released a study that claims a simulated form of a material found in the kudzu vine can minimize alcoholic drinking and help relapses
August 12th, 2009
The National Center for Health Statistics released a report that details, in the United States, the average age of motherhood has risen from 21.4 years in 1970 to 25 in 2006.
August 12th, 2009
A group of Canadian scientists claim to have successfully suppressed the immune system of an experimental group of mice, thereby reversing multiple sclerosis into remission.
August 12th, 2009
Scientists continue to unravel a new discovery surrounding a recently approved class of antibiotics and its effect on cancer.
August 11th, 2009
Astellas Pharma US Inc. has publicized the US Food and Drug’s rejection of the company’s Citizen Petition to secure the safe and valuable use of immunosuppressants.
